T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2017 12:00 pm UTC| Business
LEXINGTON, Mass., Sept. 18, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough, president...
ADP Selects CallidusCloud for Litmos Learning
Sep 18, 2017 12:00 pm UTC| Business
DUBLIN, Calif., Sept. 18, 2017 -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today that ADP selected Litmos Mobile...
Emergent BioSolutions Awarded $63 Million BARDA Contract to Develop Treatment for Cyanide Exposure
Sep 18, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Sept. 18, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development...
iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products
Sep 18, 2017 12:00 pm UTC| Business
NEW YORK, Sept. 18, 2017 -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, with its subsidiary, iBio CDMO LLC in Bryan/College Station, Texas ("iBio CDMO"), has partnered with TheoremDx, Inc., in Edina, Minnesota, to develop...
Athenex, Inc. Added to Russell 2000® and Russell 3000® Indexes
Sep 18, 2017 12:00 pm UTC| Business
BUFFALO, N.Y., Sept. 18, 2017 -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today...
Intra-Cellular Therapies to Participate at Upcoming Investor Conferences
Sep 18, 2017 12:00 pm UTC| Business
NEW YORK, Sept. 18, 2017 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today announced it will...
Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting
Sep 18, 2017 11:55 am UTC| Business
LOS ANGELES, Sept. 18, 2017 -- Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current...